• Info
  • Home
  • About
  • Editorial Board
  • Archive
  • Research Topics
  • Review Guidelines
  • Subscribe to Alerts
  • Search
  • Article Type

    Publication Date

  • Author Info
  • Why Submit?
  • Fees
  • Article Types
  • Author Guidelines
  • Submission Checklist
  • Contact Editorial Office
  • Submit Manuscript
Start date should be earlier than end date. OK Please enter the date in dd/mm/yyyy format or use the calendar icon to the left of the date field.

SPECIALTY SECTIONS IN THIS JOURNAL

RECENT FOCUSED REVIEWS

Articles

Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

Brian Godman, Bjorn Wettermark, Menno Van Woerkom, Jessica Fraeyman, Samantha Alvarez-Madrazo, Christian Berg, Iain Bishop, Anna Bucsics, Stephen Campbell, Alexander E Finlayson, Jurij Furst, Kristina Garuoliene, Harald Herholz, Marija Kalaba, Ott Laius, Jutta Piessnegger, Catherine Sermet, Ulrich Schwabe, Vera V Vlahović-Palčevski, Vanda Markovic-Pekovic, Luka Voncina, Kamila Malinowska, Corinne Zara and Lars L Gustafsson

Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiatives across Europe to lower generic prices and enhance their utilisation. However, considerable variation in their use and...

Front. Pharmacol. doi: 10.3389/fphar.2014.00106
Articles

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

Brian Godman, Rickard Malmstrom, Eduardo Diogene, Sisira Jayathissa, Stuart McTaggart, Thomas Cars, Christoph Baumgärtel, Anna Brzezinska, Anna Bucsics, Stephen Campbell, Alexander Finlayson, Jurij Furst, Kristina Garuoliene, Iñaki Gutiérrez-Ibarluzea, Krystyna Hviding, Harald Herholz, Roberta Joppi, Marija Kalaba, Ott Laius, Kamila Malinowska, Hanne B Pedersen, Vanda Markovic-Pekovic, Jutta Piessnegger, Gisbert Selke, Catherine Sermet, Dominik Tomek, Luka Voncina, Vera Vlahovic-Palcevski, Janet Wale, Magdelena Wladysiuk, Menno Van Woerkom, Corinne Zara and Lars L Gustafsson

Background: There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are effectiveness, safety and/ or budget concerns. Dabigatran, a new oral anticoagulant for...

Front. Pharmacol. doi: 10.3389/fphar.2014.00109

RECENT ARTICLES FROM SPECIALTIES

PENDING ARTICLES IN SPECIALTIES

HIGHLIGHTS

Message Board

Adv
Adv
Adv
Adv
Adv

Featured research Topic

'Guided Propagation of spontaneous activity' involving neurobiological mechanisms

Hosted by: Dominique Béroule, Pascale Gisquet-Verrier and Jean-Pol Tassin

Submit by: March 01, 2015

FEATURED ACADEMIC

img

Salah Mécheri Institut Pasteur Frontiers Review Editor

© 2007 - 2014 Frontiers Media S.A. All Rights Reserved